University of Louisville

ThinkIR: The University of Louisville's Institutional Repository
Electronic Theses and Dissertations
5-2011

Roles of VAMP3 in melanoma cell migration and integrin
trafficking.
Yaman Babi 1981University of Louisville

Follow this and additional works at: https://ir.library.louisville.edu/etd

Recommended Citation
Babi, Yaman 1981-, "Roles of VAMP3 in melanoma cell migration and integrin trafficking." (2011).
Electronic Theses and Dissertations. Paper 59.
https://doi.org/10.18297/etd/59

This Master's Thesis is brought to you for free and open access by ThinkIR: The University of Louisville's Institutional
Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator
of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of the author, who
has retained all other copyrights. For more information, please contact thinkir@louisville.edu.

ROLES OF V AMP3 IN MELANOMA CELL MIGRATION
AND INTEGRIN TRAFFICKING

By
Yaman Babi
BSc. University of Sharjah, 2004

A Thesis Submitted to the Faculty of the School of Medicine at University of Louisville
in partial Fulfillment of the Requirements for the degree of

Master of Science

Department of Biochemistry & Molecular Biology
University of Louisville
Louisville, Kentucky
May 2011

ROLES OF VAMP3 IN MELANOMA CELL MIGRATION AND INTEGRIN
TRAFFICKING

By
Yaman Babi
BSc. University of Sharjah, 2004

A thesis approved on

December 21, 2010

By the following thesis committee

………………………………
Thesis Director (Chuan Hu)
………………………………
Barbara J. Clark
………………………………
Thomas Geoghegan
………………………………
David Powell

ii

DEDICATION

This thesis is dedicated to:

My dearest parents, brothers and sisters,
My husband,
And my friends
For their patient support and continuous encouragement.

III

ACKNOWLEDGEMENTS

I would like to express my gratitude to my thesis advisor, Dr. Chuan Hu. His
encouragement and assistance over the past two years is greatly appreciated. I would like
also to thank my committee members Dr. Barbara Clark, Dr. Thomas Geoghegan and Dr.
David Powell for their support and advice. I also would like to thank the member's of Dr.
Hu lab, Dr. Nizarul Hasan, Dr. Krista Riggs and Mrs. Deborah Corbin for their guidance,
assistance and friendship. Moreover, I would like to thank my family for their support
and encouragement as this educational opportunity became part of my life for two and a
half years.
This thesis project was supported by a Clinical & Translational Science Pilot
Grant at the University of Louisville.

IV

ABSTRACT

ROLES OF V AMP3 IN MELANOMA CELL MIGRATION AND INTEGRIN
TRAFFICKING

Yaman Babi

Dec 21, 2010

Integrins are major receptors for cell adhesion to the extracellular matrix, and play
key roles in various cellular processes including adhesion, migration, proliferation and
survival. Apart from developmental and physiological events, integrins are involved in
many pathological conditions including cancer metastasis. During cell migration, the
exocytosis of integrins at the cell front contributes to the formation and stabilization of
protrusions. Previous studies showed that VAMP3, a SNARE protein that mediates
exocytosis, is important in integrin trafficking and cell migration. However, the
mechanism by which VAMP3 participates

III

integrin trafficking is not clear. Since

VAMP3 is over expressed in melanoma, the current study determines the roles of
VAMP3 in melanoma cell migration and integrin trafficking. shRNA-induced silencing
of VAMP3 inhibited the migration of B 16F 10 melanoma cells by more than 60% without
affecting cell proliferation. VAMP3 knockdown diminished cell adhesion to Matrigel and
fibronectin. Furthermore, VAMP3 silencing resulted in the accumulation of ~ 1, a3 and
a5 integrins in lysosomes, indicating that VAMP3 mediates vesicle trafficking of a3 ~ 1

v

and

a5~1

integrins. For the first time, this study examined the effect of VAMP3

knockdown on metastasis of melanoma in vivo using an experimental metastasis assay in
nude mice. It seemed that melanoma cells can metastasize to the lung even when VAMP3
is depleted and we suggest more quantitative experiments to determine the effect of
VAMP3 knockdown in melanoma pulmonary metastasis in vivo.
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CHAPTER I: INTRODUCTION

Metastasis and cell migration
Metastasis

(Greek:

displacement,

/J'cTa=next

+ mamc;=placement, plural:

metastases) is the process of spreading a disease from one organ to another non-adjacent
organ. Metastases are responsible for about 90% of the deaths in cancer patients. Cancer
metastasis by definition consists of a series of sequential steps in which some cancer cells
escape from the original tumor site and migrate to other parts of the body through the
bloodstream, or the lymphatic system. Metastasis start when some malignant cells break
away from the primary tumor and degrade the proteins that make up the surrounding
basement membrane which separates the tumor from adjoining tissues. By degrading
these proteins, cancer cells are able to breach the ECM and invade (1) (Fig 1). Cell
migration is a fundamental step in cancer metastasis.
Cell migration in specific direction and to a specific site in the body is required
in wound healing, immune responses and embryonic tissue formation and development.
Errors during cell migration have serious consequences, including mental retardation,
vascular diseases and cancer metastasis. An understanding of the mechanism by which
cells migrate might lead to the discovery of novel therapeutic strategies, that can help in
controlling invasive tumour cells.

1

Figure 1. Cancer metastasis cascade. Cancer metastasis consists of a series of

sequential steps, including local tumor growth, invasion by transmigration through
basement membranes and surrounding tissues, intravasation into blood vessels,
dissemination and survival in the bloodstream, extravasation and re-establishment of
tumor colonies at distant sites.
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Macrometastasis

Chemotaxis is the process by which cells migrate

In

animal tissue toward a

specific external signal (2) (Figure 2). The migration of single mammalian cell can be
viewed under the microscope as the cells move randomly on a glass slide. By observing
that, changes in the moving cell shape is noticed and its leading front has a characteristic
behavior. This part of the cell is highly active, sometimes spreading forwards quickly,
sometimes retracting, othertimes ruffling, or bubbling. It is widely considered that the
leading front is the main engine which moves the cell forward (3).
There is still great uncertainty on how cell migration really works. However,
because the locomotion of all mammalian cells has several common features, the
underlying cell migration processes are believed to be similar. The two main constant
features are: 1) the behavior of the leading part of the cell; 2) the dorsal surface of the cell
moves backwards and towards its trailing part. The latter feature is most easily observed
when aggregates of a surface molecule are cross-linked with a fluorescent antibody or
when small beads become artificially bound to the front of the cell (2).
Studies have demonestrated that cell front is the site where membrane is recycled
to the cell surface from internal membrane pools at the end of the endocytic cycle. This
has led to the understanding that the extension of the leading edge occurs when new
membrane is added at the front of the cell. If so, the actin filaments which form at the
front might stabilize the added membrane so that a structured extension, or lamella, is
formed rather than the cell

4

Figure 2. Chemotactic cell migration. (A) The cell is attached to the extracellular
matrix through integrin receptors on the cell surface. Upon exposure to a chemoattractant,
directionality is established by localized receptor binding that leads to activation and
accumulation of signaling events on the side of the cell facing the highest chemottractant
concentration. (B) The activated signaling events facilitate localized F-actin
polymerization leading to membrane protrusion that is independent of integrins and the
ECM. (C) The protruding psedopodium is stabilized by integrin-mediated cell adhesion.
(D) A forward translocation ofthe cell is achieved as the cell body contracts and releases
attachment sites at the rear of the cell.
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blowing bubbles at its front. Integrins, mediate cell adhesion to the ECM at the leading
edge to stabilize the lamella and serve as traction points. It is likely that these
integrins "feet" are brought to the front by added membrane at this site. The rest of the
cell is simply dragged forward. Although not clearly established, there are suggestions
that the nucleus and perhaps other large structures inside the cell may also be pulled
forward by actin filaments. In addition, it may be that the rear of the cell actively
contracts (2).

Integrins
Integrins mediate cell adhesion to extracellular matrix (ECM) proteins such as
fibronectin, laminin, collagen and vitronectin (4). Integrins define cellular shape,
mobility, and regulate the cell cycle. Some integrins playa role in the attachment of cells
to other cells. Besides the attachment role, integrin also plays a role in signal
transduction, a process by which a cell transforms one kind of signal or stimulus into
another.
Integrins are heterodimers containing two chains: the a (alpha) and
subunits. In mammals, eighteen a and eight

~

~

(beta)

subunits have been characterized and

twenty-four a/~ combinations have been described (4). The a and

~

subunits contain two

separate tails, both of which span the plasma membrane and possess small cytoplasmic
domains. Integrin subunits penetrate the plasma membrane and have very short
cytoplasmic domains of about 40-70 amino acids. The exception is the beta-4 subunit,
which has a cytoplasmic domain of 1088 amino acids, one of the largest known
cytoplasmic domains of any membrane protein. Outside the cell plasma membrane, the a
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and

~

chains lie close together along a length of about 23 nm; the final 5 nm N-termini of

each chain forms a ligand-binding region for the extracellular matrix (Figure 3).
Integrin expression pattern on the cell surface makes the cell fit into its
surrounding environment. During embryonic development, integrins are expressed very
neatly in time and space to guide the cells and make them detect where exactly they are
and where to attach. However, integrins that show modulated interactions with their
environment can transfer dramatic and far-reaching consequences upon cells. This can
give the cells the tendency to loose their original ties, recognize a different ECM
substrate and reconfigure them with features that give them the capacity to metastasize
(5). Indeed, many studies have shown that the upregulation of expression of specific
integrins is associated with the acquisition of a more metastatic phenotype (6).

Vesicle trafficking of integrins in cell migration
Emerging evidence indicates that intracellular vesicle trafficking exerts temporal
control over integrin functions (3). As transmembrane proteins, the a and

~

subunits of

integrins are synthesized and paired in the endoplasmic reticulum (7, 8), transported in
vesicles and delivered to the plasma membrane or the cell surface by exocytosis. In
migrating cells, the cell forward movement would lead to an accumulation of integrins
towards the cell rear (Fig 4). To enhance adhesion at the cell front or the leading edge,
integrins at the plasma membrane are endocytosed, transported forward by vesicles and
exocytosed at the cell front (9-11). Protein kinase Ca(PKCa) and PKC£ regulate the
exocytosis ofintegrins (12, 13).

8

Figure 3. Structure of integrin receptors. Integrin are heterodimers of a and
subunits. Both the a and

P subunits,

P

except the a4 subunit, have large ligand-binding

extracellular domains and short cytoplasmic domains. Integrins link ECM proteins on the
extracellular face of the plasma membrane to the cytoskeletal filaments on the
cytoplasmic face. Modified from (14).
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Figure 4. SNARE-mediated polarized exocytosis in cell migration. Integrins and other
plasma membrane proteins are endocytosed and transported by vesicles to the cell front.
SNARE proteins such as VAMP3 mediate the fusion of transport vesicles with the
plasma membrane. Accumulation of integrins at the cell front promotes migration.
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Accordingly, Rab GTPases which control the targeting and tethering of transport
vesicles have been shown to modulate integrin trafficking and cell mobility (11, 15).
However, not much is known about the molecular mechanism of the integrin exocytosis,
i. e fusion of integrin-containing vesicles with the plasma membrane.

SNARE proteins

SNARE proteins (§.01ub1e N-ethy1ma1eimide-sensitive factor

~ttachment

protein

receptor) are a large protein family consisting of more than 35 members in humans.
SNAREs can be divided into two main categories: vesicle or v-SNAREs, which are
incorporated into the membranes of transport vesicles during budding, and target or t-

SNAREs, which are found in the membranes of target compartments. Recent
classification divides SNARE proteins according to their structural features into RSNAREs and Q-SNAREs (16). Research in the vesicle trafficking field has demonstrated
that the interactions between v-SNAREs and t-SNAREs drive intracellular vesicle fusion
(17-19). Most SNAREs are C-terminally anchored transmembrane proteins, with their Nterminal functional domains facing the cytosol. These cytoplasmic domains of v- and tSNAREs form an extremely stable four-helix bundle (20). Energy made available from
the assembly of the SNARE complex is used to bring the vesicular and target membranes
into close proximity and drive membrane fusion (21-23) (Figure 5). What exactly not
clear is, which SNARE proteins mediate the trafficking of integrins to the plasma
membrane.
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Figure 5. SNARE proteins mediate intracellular vesicle fusion. A trans-SNARE
complex assembles when t-SNARE in the target membrane bind to the v-SNARE in the
vesicle by forming a stable 4-helix bundle which drive membrane fusion. This results in
cis-SNARE complex in the fused membrane. The adaptor protein a-SNAP binds to the
cis-SNARE complex and recruits N-ethylmaleimide sensitive fusion (NSF), which
hydrolysis ATP to dissociate the SNARE complex. The v-SNARE is then recycled for
the next round of vesicle fusion.
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I~

VAMP3

Vesicle associated membrane proteins (VAMP) are v-SNAREs found in various
post-Golgi vesicular compartments. VAMP3 or cellubrevien is a member of this family.
It is expressed in tissues and is localized to recycling endosomes and endosome-derived

vesicles (24, 25). VAMP3 has been involved in the exocytosis of a-granules in platelets
(26) as well as the recycling of endocytosed transferrin receptors (27) to the cell surface.
Recent studies suggest that VAMP3 is implicated in integrin trafficking and cell
migration (16, 28, 29). Studies have shown that tetanus neurotoxin-mediated cleavage of
VAMP3 disrupts epithelial cell migration and integrin-dependent cell adhesion (29). A
recent study from our lab showed that VAMP3-dependent integrin trafficking is crucial in
cell migration and cell adhesion to laminin (30). The goal of my thesis is to further
analyze the role of VAMP3 in integrin trafficking and cell migration, using melanoma
cells as a model.

Melanoma

About 75% of death in skin cancer patients is referred to melanoma. According to
a prediction by the American Cancer Society, in 2009 about 68,720 people in the United
States will be newly diagnosed with melanoma and about 8,650 will die of the disease. In
the United States, the percentage of people who have developed melanoma has more than
doubled in the past 30 years. The early stage melanoma is cured by surgery in most cases,
however, once melanoma cells metastasize, it is almost always fatal. Currently there is no
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effective therapy for metastatic melanoma. The median survival time of melanoma
patients with distant metastases has been reported to be 7.5 months. Therefore, new
therapeutic strategies that inhibit metastasis are urgently needed to overcome melanoma.
Melanoma is an attractive model for studying integrin roles in cancer progression
because it generally follows a sequential series of definable stages (31). During the
melanoma progression, modulations in integrin expression and signaling change the
ability of the cancer cells to interact with the environment and convert melanoma cells
from a stationary to a migratory and invasive phenotype. The expression levels of av~3,
a3~1, a4~1

and

a5~1

integrins are increased in melanoma (14). The

av~3

integrin plays

an important role during the transition of melonoma cells from the radial growth stage to
the vertical growth stage. Moreover, further progression leading to metastases may
require changes in the cell's integrins that would enhance their ability to escape from the
primary tumor, and help in their ability to invade and ultimately form metastases. It is
also conceivable that the

av~3

integrin is reexpressed during various stages of metastatic

dissemination and in particular during tumor reestablishment (31). However, it has to be
pointed out that there are some differences in integrin expression patterns depending on

in vivo (tissue) or in vitro (cell culture) analysis (14).
As shown in the microarray dataset developed by Talantov et al. (32) (Fig. 6),
V AMP3 is highly over expressed in melanoma. It is ranked in the top 1% in the Over
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Figure 6. Over expression of VAMP3 in melanoma. VAMP3 gene expression in 45
melanoma specimens (M) was analyzed using the Affymetrix human genome U133A
array, and compared to the expression in 7 normal skin (S). The original microarray
dataset was reported by Talantov et at. Box plot was generated at www.oncomine.org.
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expression Gene Rank (P = 2.86E-11). In this thesis, I hypothesize that VAMP3 mediates
integrin trafficking.

20

CHAPTER II: RESULTS AND DISCUSSION

The exocytosis of integrins at the cell front contributes to the formation and
stabilization of protrusions in cell migration. Previous studies have shown that VAMP3 is
involved in vesicle trafficking of integrins and cell migration (30). However, the
mechanism by which VAMP3 participates in integrin trafficking is not well elucidated.
Interestingly, V AMP3 is over expressed in melanoma (Fig. 6). The specific aims of my
dissertation are to: 1) determine the role of V AMP3 in melanoma cell migration and
integrin trafficking; 2) examine the role of V AMP3 in melanoma metastasis in vivo.
Using the widely used B16FIO melanoma cells as a model, I developed stable cell lines
in which VAMP3 is silenced. Using transwell migration assay and integrin
immunostaining, I analyzed the function of V AMP3 in cell migration and integrin
trafficking. Using a B16FlO experimental metastasis assay in nude mice, I examined if
VAMP3 knockdown inhibits the metastasis of melanoma in vivo.

i. Determine the role of VAMP3 in migration and integrin trafficking of melanoma
cells

Silencing of VAMP3 inhibits cell migration
Immunostaining revealed that V AMP3 is present in intracellular vesicles in the
B 16F 10 mouse melanoma cells (Fig 7A). To examine the role of V AMP3 in integrin

21

trafficking and cell migration, I depleted VAMP3 expression by shRNA gene silencing.
As shown by immunoblotting analysis (Fig 7 B), within 72 h after transfection of
shRNAs
Figure 7. Silencing of VAMP3 in B16FIO cells. (A) Subcellular distribution of

VAMP3. B 16F 10 cells were fixed, permeabilized and stained with a rabbit polyclonal
antibody to VAMP3. Representative Confocal images are shown. Arrow indicates
VAMP3 concentrated in intracellular vesicles close to the nucleus. Bar represents 20 /lm.
(B) B 16F 10 cells were transfected with two shRNAs to VAMP3: 50011515 and

50011516. 72 h later, whole cell lysates of the transfected cells were analyzed by
immunoblotting with the antibody to VAMP3. The same membrane was probed with an
antibody to

anti-~-actin

as loading control. Shown is a representative western blot of two

independent experiments.
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against VAMP3, the expression of VAMP3 protein in B16F1O cells was depleted by
more than 90%. The large reduction of VAMP3 protein indicated high efficiency of
shRNA transfection and interference. Transfection of shRNA did not modulate the
expression of ~-actin (Fig. 7B).
The effect of VAMP3 knockdown on cell mobility was analyzed using transwell
migration assay (33). Matrige1, which consists mainly of laminin and collagen, was used
as the chemoattractant. When loaded to the upper chambers of the transwells, B 16F 10
cells migrated efficiently across the membranes in a relatively homogeneous fashion (Fig
8 A). Interestingly, cells transfected with VAMP3 shRNAs had much reduced mobility.
Compared with the cells transfected with non-targeting scramble shRNA control, the
number of migrated cells transfected with the VAMP3 shRNA 50011515 decreased by
50.5% and the number of migrated cells transfected with the VAMP3 shRNA 50011516
decreased by 26% (Fig 8 B), indicating that VAMP3 diminished the chemotactic
migration of melanoma cells.
Because the shRNA 50011515 silenced VAMP3 (Fig. 7B) and inhibited cell
migration (Fig. 8), we developed B 16F 10 cell lines which stably express 50011515 to
further analyze the role of V AMP3 in integrin trafficking and migration of melanoma
cells. Since the shRNA is encoded in a vector that contains the puromycin resistant gene,
B16F1O stable cells were selected in cell culture medium with puromycin (Fig 9 A). We
expanded 24 B 16F 10 clones that are puromycin resistant and used immunoblotting to
determine VAMP3 expression in the 24 clones (part of the immunoblotting is shown in
(Fig 9 B)). VAMP3 protein was depleted
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Figure 8. VAMP3 knockdown inhibits cell migration. (A) 72 h after transfection with

the VAMP3 shRNAs 50011515 and 50011516, or a scrambled control shRNA, 5 x 105 of
B 16F 10 cells were harvested and loaded to the top chambers of transwells. Matrigel (20
J.lg/ml) was included in the lower chambers as a chemoattractant. After 24 h, unmigrated
cells were removed and migrated cells were Giemsa stained. Representative images of
migrated cells are shown. (B) Random images were taken for each transwell. The number
of migrated cells in each image was qualified using the ImageJ software then averaged
for each experimental group. The number of migrated cells transfected with the VAMP3
shRNAs was normalized to the number of migrated cells transfected with the scramble
shRNA. Error bar represent standard deviation of 3 independent experiments in which
two transwells were used for each transfection. ***p < 0.001 vs. control shRNA, **p <
0.01 vs. control shRNA.
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After 2 weeks, 24 stable

clones were picked, expanded and screened for silencing of VAMP3 by immunoblotting.
(B) Whole celllysates of 9 of the clones were immunoblotted with a VAMP3 antibody.

The same membrane was probed with an antibody to
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almost completely in Clones 3 and 4. These two cell lines were expanded and further
immunoblotting analysis confirmed the depletion of VAMP3 in Clone 3 and Clone 4 to
undetectable level compared with wild type B16F1O cells (Fig. 10). These data indicate
VAMP3 in B16FI0 melanoma cells is silenced efficiently using shRNA.
Then we assessed the effect of VAMP3 knockdown on the proliferation of
B16F1O cells. Clearly, the stable cell line Clone 3 proliferated at the same rate as the wild
type cells (Fig 11 B). This was an indication that VAMP3 was not required for cell
survival or proliferation, and ruled out the possibility that the observed reduction in the
number of migrated cells (Fig 8 A & B) was a result of decreased cell viability.
Microscopic images of the wild type, Clone 3 and Clone 4 cells showed no obvious
morphological differences (Fig 11 A). However, the pellets of Clone 3 and Clone 4 cells
look darker in color compared to the wild type cells (data not shown), suggesting that
secretion of the melanin pigment in the VAMP3 knockdown melanoma cells was
disrupted.
The transwell migration assay performed on the wild type and Clone 3 and Clone
4 cells showed 54% reduction of migration of Clone 3 cells and 39% reduction of
migration of Clone 4 cells compared with the wild type cells (Fig 12 B). When Clone 3
cells were transfected with a plasmid that encodes human VAMP3, cell motility was
rescued back to the wild type level (Fig 12 C), further indicating that migration of Clone
3 cells was inhibited due to the knockdown ofVAMP3. Due to the fact that Clone 3 cells
have more reduced cell migration than Clone 4 cells, Clone 3 cells were used in later
studies to determine the effects ofVAMP3 knockdown on melanoma metastasis in vivo.
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Figure 10. VAMP3 expression in stable cell lines that express VAMP3 shRNA.
Whole cell lysate of wild-type B 16F 10, Clone 3 and Clone 4 cells were immunoblotted
with an antibody to VAMP3. The same membrane was blotted with an antibody to
actin as a loading control.
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Figure 11. VAMP3 silencing has no effect on cell morphology and proliferation.

(A) Representative light microscopy images for B16FlO wild type cells and clones 3
and 4. (B) VAMP3 silencing has no effect on cell proliferation. Same amount of wildtype and Clone 3 cells were seeded in 24 well plate. At 0, 24, 48, or 72 h after
seeding, the number of living B 16F 10 wild type and clone3 were measured using the
CellTiter 96 A Queous One Solution Cell Proliferation Assay by absorbance at
490nm. The error bars represent standard deviation of three independent experiments.
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Figure 12 .. Migration is inhibited in Clone 3 and Clone 4. (A) B16FlO while type

cells and Clone 3 and 4 were harvested and loaded to the top chambers of transwells.
Matrigel (20 Jlg/ml) was included in the bottom chamber as chemoattractant. After 24h at
37C unmigrated cells were removed and migrated cells were Giemsa stained.
Representative images of migrated cells are shown. (B) Random images were taken for
each transwell and the number of migrated cells in each image was quantified using the
Image] software then averaged for each experimental group. The number of migrated
cells in Clone 3 and Clone 4 were normalized to the number of migrated cells of B 16F 10
wild type. Error bar represents standard deviation of 4 independent experiments. (C)
Expression of human VAMP3 rescues the inhibition of cell migration by VAMP3
shRNA. The motility of wild-type, Clone 3 and Clone 3 cells transfected with a plasmid
that encodes human V AMP3 was compared using the transwell migration assay. Error
bars represent standard deviation of 4 independent experiments.
type B 16F 10 cells.
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Different from the transwell migration assay, which exammes chemotactic cell
migration, wound healing assay (34) analyzes 2-dimensional random migration. The wound
healing assay was used to analyze if VAMP3 silencing affects 2-dimensional migration (Fig
13). Monolayers of B 16F 10 wild type and Clone 3 cells were wounded, and migration of the
cells into the wounded areas was photographed until the wounds were closed. Both the wild
type and Clone 3 cells entered the wounded space within 24 h, but Clone 3 cells showed

~

10% narrower wound. 48 h after wounding, both the wild type cells and Clone 3 cells have
closed

~90%

of the wounded areas. The slight difference in migration through the wound

between the wild type and Clone 3 cells at 24 h, and the similar migration of both cells at 48
h, conclude no obvious difference of 2-dimensional migration between the two cell lines in
the absence of chemoattractant.

Silencing of V AMP3 inhibits cell adhesion to fibronectin and Matrigel
Having shown that V AMP3 is required in chemotactic migration of B 16F 10
cells, I sought to measure the effect of V AMP3 knockdown on cell adhesion to the ECM
proteins Matrigel and fibronectin. Compared with wild type cells, at 10 min, 30 min and
60 min, adhesion of Clone 3 cells to Matrigel was attenuated by 13%, 20% and 40%,
respectively (Fig 14 A). At 60 min and 90 min, adhesion of Clone 3 cells to fibronectin
was decreased by 35% and 32%, respectively (Fig 14 B). These data indicate that
silencing of V AMP3 suppressed adhesion of melanoma cells to Matrigel and fibronectin.
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Figure 13. Wound healing assay. B16FIO cells wild type and Clone 3 was seeded at 5 x

104 cells/well in a 6-well plate. At 90% confluency, a wound was made through the cell
mono layers using a pipette tip. After 0, 6, 24 and 48 h, images were taken on a light
microscope. Representative images of two experiments are shown.
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Figure 14. Silencing of VAMP3 decreases cell adhesion to Matrigel and fibronectin.

B 16F 10 wild type cells and clone3 were added to (A) Matrigel-coated plates (B) or
fibronectin-coated plate. At different time points, unattached cells were gently washed
away, and the number of adherent cells was measured using a colorimetric assay by
absorbance at 490nm. Error bars represent standard deviation of two independent
experiments. ***p < 0.001 vs. wild type B16FlO cells.
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Effects ofVAMP3 silencing on integrin trafficking in B16FIO cells

Cell adhesion to fibronectin is mediated by integrins. The chief components of
Matrigel are ECM proteins such as laminin and collagen. In particular, the

~

1 integrin

pairs with as, aV or a8 integrin subunits to form heterodimeric fibronectin receptors,
with a3, a6 or a7 to form laminin receptors, or with aI, a2, aIO or all to form collagen
receptors (4). The inhibitory effects of VAMP3 knockdown on adhesion to fibronectin
and Matrigel suggest that V AMP3 knockdown disrupted the trafficking of integrins to the
cell surface. We postulated that if VAMP3 mediates integrin trafficking, silencing of
VAMP3 would reduce cell surface integrin expression and result in accumulation of
integrins in intracellular vesicles. However, when B 16F 10 wild type and Clone 3 cells
were stained with polyclonal antibodies against

~I,

a3 and as integrins (Fig IS A and B),

we were unable to detect obvious effects of VAMP3 depletion on subcellular distribution
of those integrins. The best integrin antibodies that are used in our lab to stain a3, as and
~I

(30, 3S) are mouse monoclonal antibodies. Because BI6FIO cells are mouse

melanoma cells, those monoclonal antibodies were not suitable for the detection of
integrins in B 16F 10 cells. The specificity of the rabbit and goat poly clonal antibodies
used in (Fig. IS) needs further validation. To circumvent this problem to determine which
integrin receptors are delivered by VAMP3, we decided to use the human cancer cell
lines HeLa (cervical cancer) and HI299 (lung cancer).
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Figure15. VAMP3 depletion has no obvious effect on integrins distribution. (A)
Unpermeabilized B 16F 10 wild type and Clone 3 cells were stained with polyclonal
antibodies to

~ I,

a3 or a5 integrins. (B) Permeabilized B 16F I 0 wild type and clone 3

cells were stained with polyclonal antibodies to

~ 1,

a3 or a5 integrins. Bar represents

20.0 flm. Representative confocal images of five experiments are shown.
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a5integrin

ii. Determine the role of VAMP3 in integrin trafficking in HeLa and H1299 cells

Silencing of VAMP3 inhibits cell migration
siRNAs against VAMP3 were used to silence VAMP3

In

HeLa cells.

Immunoblotting analysis showed that within 72 h after siRNA transfection, the
expression of VAMP3 protein in HeLa cells was depleted by more than 95% (Fig 16 A).
Transfection of VAMP3 siRNA did not modulate the expression of ~-actin.
The effect of VAMP3 knockdown on HeLa cell mobility was analyzed using the
transwell migration assay and matrigel as the chemoattractant. When loaded to the upper
chambers, HeLa cells migrated efficiently across the membranes (Fig 16 B). HeLa cells
transfected with VAMP3 siRNA had much reduced mobility. Compared with the cells
transfected with a non-targeting control siRNA, the number of migrated VAMP3
knockdown cells decreased by 65% (Fig 16 C), indicating that VAMP3 was required in
the migration of HeLa cells.

Silencing of VAMP3 inhibits cell adhesion to fibronectin and laminin
The next step was to determine the effects of VAMP3 silencing on HeLa cell
adhesion to ECM proteins. At 10 min, 20 min and 30 min, VAMP3 silencing inhibited
cell adhesion to fibronectin by 10%, 20% and 35% respectively (Fig 17 A). In addition,
VAMP3 silencing inhibited adhesion to laminin by 20-25 % (Fig 17 B). These data
suggested that VAMP3 participated in the trafficking of the integrin receptors for
fibronectin and laminin.

Figure 16. VAMP3 knockdown inhibits migration of HeLa cells. (A) HeLa cells were
transfected with negative siRNA control or a siRNA against VAMP3 (Hs-VAMP3 _5).
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72h after transfection whole celllysates were immunoblotted with antibodies to VAMP3.
The same membrane was blotted with antibodies to p-actin as a loading control. (B) 72h
after transfection with negative siRNA control or VAMP3 siRNA, HeLa cells were
harvested and loaded in the top chamber of transwells. Matrigel (20/lg/ml) was included
in the lower chamber as chemoattractant. After 24h at 37 C unmigrated cells were
0

removed while the migrated cells were Giemsa stained. Representative images of the
migrated cells are shown. (C) Random images were taken for each transwell, and the
number of migrated cells in each image was quantified using the ImageJ software then
averaged for each experimental group. The number of migrated cells transfected with
VAMP3 siRNA was normalized to the number of migrated cells transfected with
negative siRNA control. Error bar represents standard deviation of two independent
experiments in which two transwells were used for each transfection.
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Figure 17. Effects of VAMP3 knockdown on the adhesion of HeLa cells to
fibronectin and laminin. 72h after transfection with negative control siRNA (gray
columns) or VAMP3 siRNA (black columns), HeLa cells were added to fibronectincoated plates (A) or laminin-coated plates (B). At different time points, unattached cells
were washed away, and the number of adherent cells was measured using a colorimetric
assay by absorbance at 490nm. Error bars represent standard deviation of three
independent experiments.

*P

< 0.05 vs. cells transfected with negative control siRNA,

**p < 0.01 vs. cells transfected with negative control siRNA, ***p < 0.001 vs. cells
transfected with negative control siRNA.
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VAMP3 is required for trafficking of PI, a3 and a5 integrins to the cell surface
To analyze the role of VAMP3 in vesicular trafficking of integrins, we
determined the effects ofVANP3 silencing on subcellular distribution of a3~1 and

a5~1

integrins by immunostainig and confocal microscopy. Silencing ofVAMP3 in HeLa cells
resulted in the accumulation of ~ 1, a3 and a5 integrins in intracellular vesicles as shown
by staining of permeabilized cells (Fig 18 A). Surprisingly, VAMP3 knockdown had no
obvious effects on cell surface expression of
accumulation of

~ 1,

~1,

a3 and a5 integrins (Fig 18 B). The

a3 and a5 integrins inside the cells indicated that VAMP3

knockdown disrupted the trafficking of ~ 1, a3 and a5 integrins to the plasma membrane,
suggesting that VAMP3 mediates the delivery of

a3~1

and

a5~1

inetgrins to the cell

surface. Disrupted integrin trafficking is consistent with reduced chemotactic migration
and adhesion to fibronectin (a

a5~1

ligand) and laminin (a

a3~1

ligand) of VAMP3

knockdown in HeLa cells (Figs 16 C and 17) in the VAMP3 knockdown cells.
Further investigation was performed to track integrins inside the VAMP3
knockdown cells. Permeabilized HeLa cells transfected with the control siRNA or
VAMP3 siRNA were immunostained for ~ 1, a3 and a5 integrins after incubation with
Lyso Tracker Red DND-99 which tags the lysosomes. As shown by confocal microscopy
(Fig 19), in VAMP3 knockdown cells a large fraction 40%, 60% and 20% of a3, a5 and
~ 1 integrins

(respectively) were localized in lysosomes. In the control cells (Fig. 19), few

lysosomes were detected, whereas in the VAMP3 knockdown cells, the number of
lysosomes was increased at least
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--~--------

Figure 18. VAMP3 is required for the trafficking of a3, as and

PI

integrins to the

cell surface. (A) 72h after transfection with negative siRNA control or VAMP3 siRNA,
permeabilized HeLa cells were stained with monoclonal antibodies to a3, a5 and

~1

integrins. Representative Confocal images of two experiments are shown. (8)
Unpermeabilized HeLa cells were stained with monoclonal antibodies to a3, a5 and

~1

integrins. Representative confocal images of two experiments are shown. Arrows indicate
intracellular vesicles.
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~1

integrin

Figure 19. In VAMP3 knockdown cells integrins are accumulated in lysosomes. 72h

after transfection with negative control or VAMP3 siRNAs, HeLa cells was incubated
with Lyso Tracker Red DND-99, fixed, permeabilized and stained with antibodies
(green) to a3 integrin (A), a5 integrin (B) or

~1

integrins (e). Representative confocal

images of two experiments are shown. Arrows indicate integrins localization to
lysosomes.
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Merged

several folds. Together, these data suggested that when trafficking of

~l,

a3 and a5

integrins to the plasma membrane is inhibited, the integrins are targeted to lysosomes for
degradation.
To determine if VAMP3 mediates the trafficking of a3 ~ 1 and a5 ~ 1 integrins in
other cells, the H 1299 lung cancer cell line was used. Immunoblotting analysis showed
that within 72 h after transfection of siRNA against VAMP3, the expression of VAMP3
protein in H1299 cells was depleted by more than 95% (Fig 20 A). Like HeLa cells,
silencing ofVAMP3 in H1299 cells led to the accumulation of ~1, a3 and a5 integrins in
intracellular vesicles (arrows in Fig 20 B). In contrast, V AMP3 knockdown had no effect
on cell surface expression of ~1, a3 and a5 integrins (Fig 20 B & C). The accumulation
of ~ 1, a3 and a5 integrins inside the V AMP3 knockdown cells indicates that V AMP3
mediates the trafficking of ~ 1, a3 and a5 integrins in H 1299 cells.

iii. Examine the role of VAMP3 in melanoma metastasis in vivo

V AMP3 is over expressed in melanoma (Fig. 7). Data presented in this thesis
suggest that silencing of VAMP3 inhibited chemotactic migration of melanoma cells in
vitro (Fig. 8 and 12). These findings prompted us to examine whether metastasis of
melanoma in vivo can be inhibited by silencing V AMP3. B 16F 10 melanoma cells are
widely used as a syngeneic model to study melanoma metastasis. Preliminary studies in
our lab have showed that B 16F 10 cells injected in the tail vein of nude mice metastasize
to the lung and form tumor lesions. In the present study we used nude mice to study the
effects of V AMP3 silencing on the growth and metastasis of B 16F 10 tumor cells to the
lung.
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Figure 20: VAMP3 is involved in the trafficking of PI, a3 and a5 integrins in Hl299
cells. (A) 72h after transfection with negative control siRNA or VAMP3 siRNA 1,
penneabilized HI299 cells were stained with antibodies to PI, a3 or a5 integrins.
Representative Confocal images of two experiments are shown. (B) Staining of
unpenneabilized HI299 cells show no effect ofVAMP3 knockdown on surface PI, a3 or
a5 integrins. Representative Confocal images of two experiments are shown. Arrows
indicates intracellular vesicles.
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VAMP3 knockdown had no effect on the growth of melanoma
To investigate if tumor growth in vivo is affected by VAMP3 knockdown,
parental B16FlO and the Clone 3 cells that express a VAMP3 shRNA were injected
subcutaneously into the anterior flank of nude mice. B 16F 10 cells form tumor rapidly.
Within 5 days after injection, measurable tumors were detected (Fig. 21). 12 days after
injection most tumors have reached 1.5 cm in diameter, and the experiment had to be
terminated. In two independent experiments, no statistically significant differences were
observed between the Clone 3 tumors and the wild-type B16F10 tumors (Fig 21),
suggesting that silencing of VAMP3 has no effect on melanoma tumor growth. These
results are consistent with the observation that VAMP3 knockdown has no effect on
B 16F 10 proliferation in vitro (Fig. 11).

Effects of VAMP3 silencing on melanoma metastasis
The metastatic B16FlO melanoma cells injected through the tail vein of nude
mice results in pulmonary metastases (36). In preliminary experiments, we found that two
weeks after injection of wild type B16FlO cells, lung metastases were developed in nude
mice (data not shown). To test the possible inhibitory effect of VAMP3 knockdown on
metastasis, the same number of B 16F 10 and Clone 3 cells were injected into nude mice.
Two weeks later, the mice were sacrificed and the lung tissues were collected and
examined. In the first experiment, (Fig 22 A) all three mice injected with B16FlO cells
developed pulmonary metastases, whereas only two out of four mice received the Clone 3
cells developed metastases,
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Figure 21: Subcutaneous tumor growth assay. Nude mIce model was used to
investigate whether tumor growth in vivo can be inhibited by VAMP3 knockdown.
B 16F 10 cells and Clone 3 expressing VAMP3

knockdown were implanted

subcutaneously into the anterior flank skin of nude mice, and tumor growth was
compared in the two groups of animals (each group include 5 mice). In two independent
experiments, measurable tumors were detected within 5 days after injection, (Fig. 21). 12
days after injection most tumors have reached the size of 1.5 cm in diameter, and the
experiment had to be terminated .. Tumors were measured by calipers and the tumor's
volume was calculated using the following formula: Tumor volume (mm3)

=

12 (Length x

width2 ). No significant effect of VAMP3 knockdown on tumor growth was observed.
***p <0.001 vs. the mice injected with wild type B16FlO cells.

58

Day 5

3500

;;:;-

Group 1 (Wt)

~ 3000
--

E 2500

0 Group 2 (Clone 3)

:::l

2000

o

>.....

E 1500
:::l

~ 1000
o

~

500

Q)

~

O +---~~~-----L--~--~

Exp. 1

• Group 1 (Wt)
~- 140

E

Exp. 2

Day 12

o Group 2 (Clone 3)

~120
a>

E 100
~

0

> 80
'0

E
~

60

Ia>

..s:::.

0

c:::

40
20

co
a>

:::E

0
Exp.1

Exp.2

59

Figure 22. Experimental lung metastasis assay. B16FlO wild type cells and Clone 3
were injected into the tail veins of a group of nude mice. Each cell line was injected in 4
mice in two independent experiments. Two weeks after tumor cell injection, mice were
sacrificed to examine the inhibitory effect on lung metastasis of VAMP3 knockdown.
Representative lungs are shown in (Fig 22 A and B). Extensive tumor metastasis was
found in the wild type and Clone 3 groups and the lungs from mice injected with both
cell lines showed cancer lesions indicated by arrows.
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suggesting that in this experiment silencing of VAMP3 may have an inhibitory effect on
metastasis of melanoma to the lung. However, in another experiment (Fig. 22 B), Clone 3
cells metastasized to the lung comparable to wild type B 16F 10 cells.

From these

experiments we conclude that melanoma cells can still metastasize even when VAMP3 is
depleted. Further experiments are needed to determine quantitatively if VAMP3
knockdown has inhibitory effects on metastasis. In addition, we may need to sacrifice the
mice at a shorter time point to detect any differences between the two cell lines before
they reach the same degree of metastasis.

Discussion

In migrating cells, integrins are transported in vesicles and exocytosed actively at
the cell front (37). Although it is well established that SNAREs mediate intracellular
vesicle fusion (18, 19), it is not clear which SNARE proteins mediate the trafficking of
integrins to the plasma membrane. Using RNA interference, we show here that silencing
of the v-SNARE VAMP3 effectively inhibit both melanoma cell migration, as well as,
melanoma cell adhesion to Matrigel and fibronectin without affecting cell proliferation.
VAMP3 silencing led to the accumulation of ~ 1, a3 and a5 integrins in vesicles in HeLa
and H 1299 cells, indicating that VAMP3 is required for trafficking of these integrins to
the plasma membrane. Together, these data suggest that VAMP3 plays an important role
in migration and adhesion of melanoma cells and that VAMP3 mediates the trafficking of
a3~ 1 and a5~ 1 integrins.

By expression of catalytic light chain of tetanus toxin (TeTx-LC), a protease that
specifically cleaves and inactivates VAMPI, VAMP2 and VAMP3, several studies show

62

that inhibition ofVAMP3 function interferes with cell motility and integrin functions. In
CHO cells, expression of TeTx-LC impairs cell migration, reduces cell surface a5~1
integrin, and inhibits cell spreading but not adhering to fibronectin (16,28). In MDCK
cells, TeTx-LC expression reduces cell motility and disrupts the recycling

of~1

integrin

(29). Since among the three VAMP proteins, VAMP3 is the only one expressed in CHO
cells and MDCK cells (16, 29), these results suggest that VAMP3 participates in integrin
trafficking and cell migration. In the present study, we used shRNA and siRNA to silence
VAMP3 and found that VAMP3 silencing inhibited the migration of B 16F 10 and HeLa
cells by more than 60% and effectively disrupted integrin trafficking. This work provides
further evidence that VAMP3-dependent integrin trafficking plays an important role in
cell migration. Although trafficking of a3 ~ 1 and a5 ~ 1 integrin is disrupted, cell surface
expression of the integrins in the VAMP3 knockdown cells is not altered. This
observation is not surprising, since our lab has shown that other v-SNAREs such as
VAMP2 also mediates vesicle trafficking of integrins to the cell surface.
Like other receptors, integrins at the cell surface are continually endocytosed from
the plasma membrane, transported into endosomal compartments and then recycled back
to the cell surface (38). Most endocytosed integrin molecules are recycled, rather than
being targeted to lysosomes for degradation (3, 12). The endocytosis and recycling of
integrins is particularly important during cell migration. In migrating cells, integrins act
as the "feet" to support cell adhesion to the ECM. The net forward movement of the cell
leads to an accumulation of integrins towards the cell rear. To provide a fresh source of
integrins at the cell front, integrins are endocytosed and recycled to the leading edge (9,
10). This thesis indicates that although cell surface expression of integrins in V AMP3
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knockdown cells is not altered, cell migration is inhibited dramatically. These data are in
accordance with recent findings from other groups showing that vesicle trafficking of
integrins but not the levels of integrins at the cell surface plays a major role in cell
migration (4). These data emphasize the importance of VAMP3-mediated integrin
trafficking in cell migration.
VAMP3 is over expressed

III

melanoma. To our knowledge, this is the first

systematic study on the role of V AMP3 in migration of melanoma cells. Our data
indicate that V AMP3 is required for chemotactic migration of melanoma cells in vitro.
However, in vivo analysis using the experimental lung metastasis assay has yielded
variable results. One experiment showed that V AMP3 knockdown inhibited melanoma
metastasis to the lung, whereas another experiment showed no such effect. To
metastasize to the lung, the B 16F 10 cells need to survive in the blood stream, migrate out
of the blood vessels and form colonies in the lung. The fact that we detect pulmonary
metastases of melanoma cells depleted of VAMP3 indicates that VAMP3 is not required
for the aforementioned processes. More experiments are needed to determine if there is a
quantitative difference of metastasis between wild type and V AMP3-depleted melanoma
cells.
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CHAPTER III: METHODS

Cell culture

BI6-FI0, H1299 and HeLa cells were obtained from the American Type Culture
Collection (ATCC). BI6-FI0 cells were cultured in Dulbecco's Modified Eagle medium
(DMEM) with 4.5 gil glucose and 10% fetal bovine serum (FBS). H1299 cells were
cultured in RPMI medium 1640 with 2.5 giL glucose, 1% sodium pyruvate, 1 mM
HEPES and 10% FBS. HeLa cells were cultured in Minimum Essential Medium a
(MEMa) media with 10% FBS. The cells were maintained at 37°C with 5% C02. All cell
culture media were manyfactured by Invitrogen.
To split cells, the culture medium was aspirated, and the cell culture dishes were
washed once with PBS (150 mM NaCl, 10 mM sodium phosphate, pH 7.4) containing 0.5
mM EDTA (PBS-EDTA). 2 ml of trypsin (0.05% in PBS-EDTA) was added to each dish.
After incubation at 37°C for 3-5 min, 10 ml of complete medium was added to quench
the trypsin reaction and the cells were dispersed by repeated pipetting. The cells were
transferred to 15 ml conical tubes, and centrifuged at 200 g for 10 min. The medium was
aspirated from the conical tubes and the cells were re-suspended gently in culture
medium and plated.
To store cells, cells were trypsinized and centrifuged as above, re-suspended at a
density of lxl06-1x107 cellslml in FBS supplemented with 5% DMSO (Sigma), and
transferred to cryovials. The vials were placed in a Nalgene Cryo freezing container,
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frozen at -80°C for 24 h, and then transferred to a liquid nitrogen container. To recover,
cells were thawed by warming the vials at 37°C until the frozen pellet had nearly melted.
The cells were slowly added to a 15 ml conical tube containing 10 ml of culture medium.
Cells were then centrifuged and plated as above.

Transfection of plasmids and siRNAs

The scramble shRNA, and the shRNAs 50011515 and 50011516 which target mouse
VAMP3 were obtained from Sigma. A 21 nucleotide siRNA oligo that targets human
VAMP3 sequence TCAAGCTTACCT ACTGTTA was synthesized by Dharmacon
Thermo Scientific. The AllStars Negative control siRNA was obtained from QIAGEN.
The day before transfection, BI6-FI0, HeLa or Hl299 cells were seeded into 6-well
plates (5 x 105 cells per well) or 24-well plates (5 x 105 cells per well). 1 Ilg of shRNAs
were transfected into the cells grown in each well of 6-well plates using Lipofectamine
2000 according to the manufacturer's instructions (Invitrogen). The control and VAMP3
siRNAs were transfected at 10 nM using Lipofectamine RNAiMAX.

Immunoblotting

Whole celllysates were obtained by lysing cells in 2x SDS-PAGE sample buffer.
45 III of whole cell lysates were loaded in each well of 15% SDS-PAGE gels. After
electrophoresis, proteins were transferred to Hybond-LFP (PVDF) membranes
(GEHealthcare) using 20V overnight at 4°C or to Trans-Blot Nitrocellulose Membranes
(BIO-RAD) at 0.25A at room temperature for 2 h. The membranes were preincubated
with 5% Milk in TBS (20 mM Tris-HCl pH7.6, 140 mM NaCl) with agitation overnight
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4°C or 1 h at room temperature. The membranes were then incubated with rabbit
polyclonal antibodies to V AMP3 (Synaptic Systems, 1: 1,000 dilution) for 2 h at room
temperature. The membranes were washed three times with TBS and once with TBS-T
(0.05% Tween-20 in TBS), and then incubated with HRP-conjugated goat anti rabbit IgO
antibodies (Jackson ImmunoResearch Laboratories, 1: 10,000 dilution) for 1 h. After the
antibody solution was removed, the membranes were washed as described above. Bound
antibodies were detected with SuperSignal West Pico Chemiluminescent Substrate
(Thermo Scientific Pierce). The membranes were exposed to Kodak BioMax
autoradiography films, and films were developed using HOPE micro-max developer
located in the Department of Biochemistry and Molecular Biology at the University of
Louisville. The same membranes were labeled with a mouse monoclonal antibody to
actin as loading control.

Development of stable ceUlines that express VAMP3 shRNAs
BI6-FI0 cells were transfected with the shRNA 50011515 using Lipofectamin
2000. 72 h after transfection, the cells were splitted into selective DMEM medium
containing 1 ug/ml puromycin. After two weeks, 24 clones were picked, transferred to
24-well plates and grown in puromycin-containing medium. Whole celllysates of the
clones were analyzed by immunoblotting for VAMP3 expression. Clones that had
reduced V AMP3 expression were expanded. Clones 3 and 4 were chosen for further
studies because they showed knockdown ofVAMP3, but not ~-actin.
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Immunocytochemistry
The day before transfection, cells were seeded on sterile 12-mm glass cover slips
contained in 24-well plates. 72 h after transfection, the cells were fixed with 4%
paraformaldehyde in PBS++ (PBS supplemented with 0.1 gil CaCl2 and 0.1 gl I MgCI2)
for 10 min. Cells in some wells were permeabilized with 0.2% Triton X-I 00 in PBS++
for 5 min. After washing, the cells were blocked in 10% FBS in PBS++ for 30 min.
Primary antibodies were incubated with the cells at the following dilutions:

anti-~l

integrin mouse monoclonal antibody P5D2, neat conditioned culture medium of the
hybridoma cells; anti-a3 integrin mouse monoclonal antibody (Chemicon International),
1:50; anti-a5 integrin mouse monoclonal antibody (Chemicon International), 1:50; antia3 integrin goat polyclonal antibody (Santa Cruz Biotechnology), 1:50; anti-a5 integrin
rabbit poly clonal antibody (Santa Cruz Biotechnology), 1:50. FITC-conjugated secondary
antibodies (Jackson ImmunoResearch Laboratories) were used at a dilution of 1:500. For
double staining, cells were incubated first with Lyso Tracker© Red DND-99 (Invitrogen)
(50 nM or 100 nM) for 45 minutes before fixation. Confocal images were collected at
60x on an Olympus laser scanning confocal microscope located in the Department of
Biochemistry and Molecular Biology. Images were processed with Adobe Photoshop
software.

Cell adhesion assay
Cell adhesion assay was performed as described (35). Each well of 24-well
plates was coated with 20 flg of fibronectin, Matrigel or laminin for 1 h at room
temperature. The plates were washed once with PBS and blocked with 2% heat
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inactivated BSA in PBS. 72 h after transfection, cells were harvested with trypsin/EDT A,
counted with a hemacytometer and re-suspended in serum free medium supplemented
with 0.5% BSA (SFM-BSA). 2x 105 cells were added to each well and allowed to adhere
to the coated plates for various time at 37°C. After incubation, non-attached cells were
removed by 3 gentle washes with SFM-BSA medium. Phenol red free medium and
CellTiter 96 Aqueous One Solution Reagent (Promega) were then added to measure the
number ofliving cells. After incubation at 37°C for 90 min, absorbance of the medium at
490 nm was measured in a 96-well ELISA plate reader. Absorbance from we11s
containing only the medium but no ce11s was taken as blank: reading.

Transwell migration assay

Transwell migration assay was performed as described (35).Serum-free medium
(SFM) containing 20 Ilg/ml of growth factor-reduced Matrigel was added to the lower
chambers of the 12-well format transwells (8 Ilm-pore, BD Biosciences) as
chemoattractant. 72 h after transfection, cells were harvested with trypsin/EDT A, resuspended in SFM, and added to the upper chambers at 5x 104 cells per transwell. After
24 h at 37°C, the transwells were fixed in methanol, and stained with Giemsa Stain
solution (Sigma). The unmigrated cells were removed from the top of the membranes
using cotton swabs. The membranes were detached from the transwells then affixed to
glass slides using Permount mounting medium (Fisher Scientific). To quantify the
number of migrated cells, five to ten random images were taken at lOx on a light
microscope for each transwell. The number of migrated cells per image was counted
using the Particle analysis function in ImageJ software.
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Cell proliferation assay
B16F10 cells or Clone 3 cells were seeded in 24-well plates at 5x104 cells per
well. 0, 24, 48, and 72 h later, cell culture medium was replaced with phenol red free
medium, and the CellTiter 96 Aqueous One Solution Reagent was added to measure the
number of living cells. After incubation at 37°C for 90 min, absorbance of the medium at
490 nm was measured in a 96-well ELISA plate reader. Absorbance from wells
containing only the medium but no cells was taken as blank reading.

Wound healing assay

B16FlO cells or Clone 3 cells were seeded in 12-well plate at 5x104 cells per
well. After 48 h, a cross wound was made in the cell mono layers using a 200 III pipette
tip. The cells were washed once with cell culture medium to remove cellular debris and
returned to 37°C culture. After 0, 6, 24 or 48 h, images of the wounded areas were taken
using a light microscope.

Experimental pulmonary metastasis assay

The experimental pulmonary metastasis assay was performed as described (36)
with modifications. 6 weeks old male nude mice were obtained from the National Cancer
Institute and kept in barrier facility in the Delia Baxter Building. Wild-type B16-F10 and
Clone 3 cells were detached from cell culture plates by trypsinization and suspended in
PBS at 5 x 106 cells/ml. The cell suspension was injected into the tail's vein of nude mice
using 27 gauge butterfly needles. Each mouse received approximately 0.1 ml of cell
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suspension. The mice were checked every other day. After two weeks, the mice were
euthanized and the lungs were harvested, examined and pictured for the presence of
tumor metastases. Each experimental group consisted of 4-5 mice.

Subcutaneous tumor growth assay
Wild-type B16FlO and Clone 3 cells were injected subcutaneously into the
anterior flank of nude mice at 1 x 106 cells/mice. The tumor diameters were measured
once weekly with a calipers and the tumor volume was calculated using the formula:
Tumor volume (mm3)

=

1I2(length

x

width 2) (39). Each experimental group consisted of

5 mice.
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